liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer
Östergötlands Läns Landsting, Centre of Surgery and Oncology, Department of Oncology UHL.
Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
Fernö, M., Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
Show others and affiliations
2008 (English)In: Breast, ISSN 0960-9776, E-ISSN 1532-3080, Vol. 17, no 5, 484-491 p.Article in journal (Refereed) Published
Abstract [en]

We investigate the prognostic significance of the pro-angiogenic cytokine vascular endothelial growth factor (VEGF), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor 1 (PAI-1), and S-phase fraction (SPF) for distant disease free survival (DDFS) in 219 premenopausal patients with node-negative breast cancer (NNBC). In univariate analysis significantly shorter DDFS was observed for patients with high VEGF (p = 0.006), high uPA (p = 0.001), and high SPF (p < 0.001). The prognostic significance of VEGF varied over time being very strong for early relapses (0-2.25 years follow-up) (HR = 7.9, p = 0.006) while no difference was seen in the subsequent follow-up period (HR = 1.3, p = 0.62). In a series of bivariate analyses VEGF provided prognostic information during the whole observation period (0-72 months) in addition to age, tumour size, oestrogen receptor (ER), progesterone receptor (PgR), and uPA. Also this effect was more pronounced during the first follow-up period suggesting VEGF as a marker of early recurrences. © 2008 Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
2008. Vol. 17, no 5, 484-491 p.
Keyword [en]
Early relapses, Premenopausal lymph node-negative breast cancer, S-phase fraction (SPF), Urokinase-type plasminogen activator (uPA), Vascular endothelial growth factor (VEGF)
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-49998DOI: 10.1016/j.breast.2008.02.010OAI: diva2:270894
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2010-05-24

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Department of Oncology UHL
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 31 hits
ReferencesLink to record
Permanent link

Direct link